Xolair (omalizumab; Roche/Novartis) is a recombinant humanized monoclonal antibody for the treatment of moderate to severe persistent allergic asthma.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!